- Home
- LIMN vs AACT Comparison
LIMN vs AACT Comparison
Compare LIMN & AACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIMN
- AACT
- Stock Information
- Founded
- LIMN 2018
- AACT 2021
- Country
- LIMN United States
- AACT United States
- Employees
- LIMN N/A
- AACT N/A
- Industry
- LIMN
- AACT
- Sector
- LIMN
- AACT
- Exchange
- LIMN NYSE
- AACT Nasdaq
- Market Cap
- LIMN 623.8M
- AACT 697.5M
- IPO Year
- LIMN N/A
- AACT 2023
- Fundamental
- Price
- LIMN $5.93
- AACT $11.41
- Analyst Decision
- LIMN
- AACT
- Analyst Count
- LIMN 0
- AACT 0
- Target Price
- LIMN N/A
- AACT N/A
- AVG Volume (30 Days)
- LIMN 987.0K
- AACT 331.5K
- Earning Date
- LIMN 01-01-0001
- AACT 01-01-0001
- Dividend Yield
- LIMN N/A
- AACT N/A
- EPS Growth
- LIMN N/A
- AACT N/A
- EPS
- LIMN N/A
- AACT 0.36
- Revenue
- LIMN N/A
- AACT N/A
- Revenue This Year
- LIMN N/A
- AACT N/A
- Revenue Next Year
- LIMN N/A
- AACT N/A
- P/E Ratio
- LIMN N/A
- AACT $31.55
- Revenue Growth
- LIMN N/A
- AACT N/A
- 52 Week Low
- LIMN $4.40
- AACT $10.73
- 52 Week High
- LIMN $33.66
- AACT $11.62
- Technical
- Relative Strength Index (RSI)
- LIMN N/A
- AACT 55.02
- Support Level
- LIMN N/A
- AACT $11.40
- Resistance Level
- LIMN N/A
- AACT $11.45
- Average True Range (ATR)
- LIMN 0.00
- AACT 0.04
- MACD
- LIMN 0.00
- AACT 0.00
- Stochastic Oscillator
- LIMN 0.00
- AACT 50.00
About LIMN LIMINATUS PHARMA INC
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.
About AACT Ares Acquisition Corporation II
Ares Acquisition Corp II is a blank check company.